throughout the present specification , relative positional terms like ‘ upper ’, ‘ lower ’, ‘ front ’, ‘ rear ’, ‘ top ’, ‘ bottom ’, ‘ horizontal ’, ‘ vertical ’, and the like are used to refer to the orientation of the apparatus as shown in the drawings . these terms are used in an illustrative sense to describe the depicted embodiments , and are not meant to be limitative . it will be understood that the depicted apparatus may be placed at an orientation different from that shown in the drawings , such as inverted 180 degrees or transverse to that shown , and in such a case , the above - identified relative positional terms will no longer be accurate . in fact , while the access port hereof is shown and discussed in one possible orientation thereof , it will be understood that when surgically installed in a patient , the access port may be oriented differently from the orientation shown in some of the figures . referring now to fig3 - 6 , an implantable access port apparatus , according to a selected illustrative embodiment of the present invention , is shown generally at 30 . according to one aspect of the invention , a kit may be provided which includes an access port 30 and a specialized needle 50 ( fig7 ), to be discussed subsequently . optionally , the kit may also include a guide wire 70 ( fig1 ). the access port apparatus 30 of fig3 - 6 includes a main port body 32 having a hollow chamber 34 formed therein . the main port body 32 is formed generally in a truncated conical shape with a flat top , modified to have one flat side , as shown . the bottom of the main port body 32 is generally flattened . the main port body 32 has an annular channel 33 formed therein above the chamber 34 , to receive an edge portion of a septum 38 therein . the main port body 32 is formed from a biocompatible material , such as titanium , a titanium alloy or another biocompatible corrosion - resistant metal , or from a strong biocompatible plastic . where plastic is used for the main port body 32 , a titanium liner may be provided for placement inside of the chamber 34 . the chamber 34 is formed in an orthogonally directed conical shape , resembling a bowl portion of a bubble pipe , or an old - fashioned ear trumpet , as shown . the chamber 34 is configured with a curved inner wall 35 , which slopes gradually downwardly toward an outlet aperture 42 . the inner wall 35 is concavely curved to resemble the interior of a bowl , as will be seen by comparing the cross - sectional views of fig3 and 4 . the chamber 34 is shaped essentially as a substantially orthogonally directed curved funnel , to passively direct contents thereof in a curved path toward the outlet aperture 42 . these contents may be fluids , such as medicines which have been injected into the chamber . alternatively , a tip of a guide wire 70 may be inserted into the chamber 34 , and may be guided towards the outlet aperture 42 by the shape of the chamber , as will be further discussed below . the directed conical shape of the chamber 34 promotes more complete flushing of fluids such as blood and theraputic medicated fluids therethrough , than the previously known access ports . the main port body 32 may have one or more round or ovoid eyelets 37 formed substantially vertically through edge portions thereof , to allow tissue to grow through the port apparatus 30 and anchor it in place in a patient &# 39 ; s body . these eyelets 37 , where used , may be optionally filled with a silicone elastomeric material , to facilitate removal of the access port apparatus 30 , when it is no longer needed . in either case , these eyelets 37 are designed to allow a needle to be driven through them and into tissue to tie down the port in the subcutaneous tissue the access port apparatus 30 also includes a pierceable septum 38 , attached to the main port body 32 and covering the hollow chamber 34 . the septum 38 is formed from a resiliently deformable material , such as a silicone elastomer . the septum 38 includes a thickened central portion 37 which is substantially cylindrical in shape , and a thinner edge portion 39 for placement in the annular channel 33 , to anchor the septum in place in the main port body 32 . the access port 30 of fig3 - 6 also includes a hollow outlet tube 40 , attached to the main port body 32 . the outer surface of the outlet tube 40 is configured to retentively receive a proximal end of a catheter 75 thereon ( fig1 ). the outlet tube 40 may be integrally formed as part of the main port body 32 , may be cast in place in the main port body , or may be a separate and removable piece . the outlet tube 40 is in fluid communication with the hollow chamber 34 of the main port body 32 via an outlet aperture 42 formed in the wall thereof . in the access port apparatus 30 hereof , the outlet aperture 42 is located at substantially the lowest area of the chamber 34 , as shown . in the embodiment of fig3 - 6 , it will be noted that the outlet aperture 42 is formed at the bottom of the chamber 34 . referring now to fig7 , a specialized wyr - gyd ™ needle 50 is shown , which is configured to be used with the access port 30 hereof , in a method which will be subsequently described herein . the wyr - gyd ™ needle includes a hollow , tubular needle body 51 with a curved tip 52 . the needle 50 also includes a hollow reservoir body 54 having a space 56 formed therein . the reservoir body 54 is in fluid communication with the needle body 51 , and has a directional pointer 57 formed thereon which points in the same direction as the needle tip 52 . the pointer 57 is provided to assist the user in orienting the needle 50 when it is in place in the access port 30 . referring now to fig7 - 9 , it will be seen that the needle tip 52 has sharply pointed extremity 53 so that the needle can pierce through skin and through the septum 38 of the access port 30 . the leading part of the needle is designed not to core the septum of the port . the needle tip 52 also has an opening 58 formed therein , to allow a user to feed a guide wire 70 ( fig1 ) outwardly from the needle 50 . the needle tip 52 has a non - sharp rounded lower edge portion 60 formed thereon at a lower , outwardly facing edge of the opening 58 , and also has a non - sharp rounded upper edge portion 62 formed thereon at an upper , inwardly facing edge of the opening 58 . these non - sharp edge portions 60 , 62 are important in the practice of the present invention , because where the selected guide wire 70 has a hydrophilic coating thereon , such as the teflon ® coating on the glidewire ® brand guide wires , the rounded non - sharp edge portions 60 , 62 allow such coating to slide therepast undamaged . in contrast , if a needle having sharp edge portions were used , instead of the non - sharp edge portions 60 , 62 , such sharp edges could scrape the hydrophilic coating off of the guide wire , as the guide wire is extended and retracted through the needle . the access port 30 hereof is specifically intended to be used in conjunction with a guide wire , according to a procedure which will be described below . the following procedure is only intended to be followed by medical professionals such as doctors , physician assistants or other specially trained and qualified medical personnel . for purposes of the present discussion , it will be assumed that the access port apparatus 30 of fig3 - 6 has been surgically implanted in a patient &# 39 ; s chest or arm below the skin , and that the outlet tube 40 thereof has been connected to a catheter 75 which has been installed with its distal tip in a selected location in the patient &# 39 ; s central venous system , such as , e . g ., the superior vena cava . this arrangement of the access port 30 and catheter 75 is depicted in fig1 . as a preliminary step , the area of a patient &# 39 ; s skin which covers the port 30 must be cleansed and sterilized . then , a specialized wyr - gyd ™ needle 50 is inserted through the skin of the patient , and through the septum 38 of the access port 30 , until the tip 52 of the needle 50 is inside of the port chamber 34 . the wyr - gyd ™ needle 50 is shown in place in the access port 30 in fig1 . once the needle 50 is in place , a guide wire is fed through the needle tip 52 and into the chamber 34 . one example of a suitable guide wire which is usable in the method hereof , is the polytetrafluoroethylene - coated guide wire sold by the terumo medical corporation under the trademark “ glidewire ®”. the guide wire is shown being threaded through the wyr - gyd ™ needle , through the access port 30 , and into the catheter 75 in the illustration of fig1 . the orthogonally directed , conical shape of the chamber 34 passively directs the tip of the guide wire to the outlet aperture 42 , and the guide wire is fed through the outlet aperture 42 , through the outlet tube 40 , and into the catheter 75 . since the outlet aperture 42 is located at substantially the lowest portion of the chamber 34 , this makes it easier to thread the guide wire through the outlet aperture than it would otherwise be , with the previously known ports . in contrast , in the conventional access port design where the outlet aperture is situated at an elevated level in the chamber , as it is in the prior art port 10 of fig1 - 2 , then threading a guide wire through the septum and into the outlet port is very difficult to accomplish . slowly and carefully , the wire tip is advanced in the catheter 75 until it reaches the tip thereof , and is then further advanced until it reaches the inferior vena cava ( ivc ). if a sheath 79 is present , the guide wire tip may pierce or tear the sheath 79 as it is pushed out of the catheter tip . this movement of the guide wire through the catheter 75 helps to clean any accumulated material off the interior walls thereof , but is not a complete procedure , and may not effectively remove a sheath 79 from the catheter tip . if the catheter tip has been dislodged from its normal resting place , at the junction between the superior vena cava ( svc ) and the right atrium ( ra ), as shown in fig1 , then feeding the guide wire through the catheter 75 may be all that is needed to re - position the catheter tip to the svc / ra junction . however , if it has been determined by preliminary venogram or angiogram that a blockage , such as a sheath 79 is present on the distal portion of the catheter 75 , then the next step is to access a femoral vein of the patient , and to advance a loop snare 77 through the femoral vein to the ivc . the insertion of a loop snare 77 into the femoral vein is illustrated in fig1 . the loop snare is then placed over the tip of the guide wire , and is advanced further , following the guide wire up the venous system , until it reaches the catheter tip . the loop snare is then placed over the sheath 79 and the catheter tip , as will be further described . once the loop of the loop snare reaches the tip of the catheter 75 , the loop is placed over the catheter tip , and is advanced to the proximal portion of the sheath 79 . the loop of the snare is then carefully tightened in place around the sheath 79 and catheter 75 , and is then pulled down to the exposed guide wire , thereby slidably removing any sheath 79 covering the catheter tip . this step may be repeated two or more times , to make sure that the sheath 79 has been completely removed from the catheter 75 . if the catheter tip is broken off during this step , the broken piece is retained on the guide wire , instead of floating freely in the venous system , and this retention on the guide wire makes any broken piece more easily retrievable than a loose broken piece would be . the sheath 79 may then be withdrawn along the guide wire , and removed from the body , by slowly withdrawing the loop snare through the femoral access site . after the loop snare and the sheath 79 have been removed , the guide wire 70 is then removed from the patient &# 39 ; s body . the catheter 75 and port 30 are then flushed with at least 10 ml of normal saline solution . heparin ® may be instilled into the port and catheter at this stage to resist clotting . finally , the specialized wyr - gyd ™ needle is withdrawn from the port . the site is then covered in a sterile manner , and the patient is allowed to recuperate . although the present invention has been described herein with respect to a specific illustrative embodiment , the foregoing description is intended to be illustrative , and not restrictive . those skilled in the art will realize that many modifications of the preferred embodiment could be made which would be operable . all such modifications , which are within the scope of the present disclosure , are intended to be within the scope and spirit of the present invention .
a surgically implantable access port has a main port body with an internal chamber formed therein , and an outlet tube connected to the main port body . the internal chamber is configured to readily receive a guide wire therein , and to passively direct the tip of a guide wire to an outlet , which is in fluid communication with the outlet tube . the chamber in the main port body is formed in a directionally aimed conical shape . the outlet may be located at the lowest area of the chamber , to help direct a guide wire thereto . a specialized needle is also described , having a curved tip with an opening formed therein . the top inner and the and the bottom outer surfaces of the needle , adjacent the tip opening , are rounded and non - sharp to avoid damaging a guide wire when used therewith . methods of using the port and needle are also disclosed .